Healthcare Sales & Marketing Network News: Fodosine

Searching News Database: Fodosine

HSMN NewsFeed - 8 Aug 2007
BioCryst Appoints Elliott T. Berger, Ph.D., Senior Vice President of Regulatory Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Jul 2007
BioCryst Announces Realignment and Strengthening of the Company's Executive Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Apr 2007
BioCryst Expands Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Mar 2007
BioCryst Provides Fodosine(TM) Update
Biopharmaceuticals Oncology

HSMN NewsFeed - 6 Feb 2007
EMEA Grants Orphan Drug Designation to BioCryst's Fodosine(TM) for the Treatment of Cutaneous T-Cell Lymphoma (CTCL)
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 25 Jan 2007
BioCryst Initiates Phase II Influenza Clinical Trial to Evaluate Peramivir
Biopharmaceuticals

HSMN NewsFeed - 16 Jan 2007
BioCryst Initiates Pivotal Fodosine(TM) Phase IIb Clinical Trial in Patients With Relapsed/Refractory T-Lymphoblastic Leukemia/Lymphoma
Biopharmaceuticals Oncology

HSMN NewsFeed - 8 Jan 2007
Jon P. Stonehouse Appointed Chief Executive Officer of BioCryst
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Dec 2006
Results of Clinical Trial Program Suggest Fodosine(TM) Demonstrates Clinical Activity in Certain Types of Leukemia and Lymphoma
Biopharmaceuticals Oncology

HSMN NewsFeed - 20 Nov 2006
BioCryst's Fodosine(TM) Granted Orphan Status In Europe
Biopharmaceuticals Regulatory

Return to NewsFeed

Additional items found! 9

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 9 additional stories matching:
Fodosine
(Password required)

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.